HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA appropriations

This article was originally published in The Rose Sheet

Executive Summary

FY 1995 budget for salary and expenses is $905.9 mil., according to conference report language for the agriculture appropriations legislation adopted by the Senate Sept. 28. Conference language approved by the House Sept. 23 allocating $899.4 mil. for FDA salaries and expenses did not include $6.5 mil. in mammography inspection fees. The $163 mil. in general purpose user fees originally contained in the Senate bill were removed after the House passed a resolution authored by House Ways & Means Committee Chair Sam Gibbons (D-FL) declaring the unauthorized user fees in violation of a constitutional requirement that revenue raising measures originate in the House. The 1995 FDA budge "represents an increase of $36.3 mil. to the 1994 level, but a reduction of $18.6 mil. to the overall level the Senate had proposed," Appropriations/Agriculture Subcommittee Chair Dale Bumpers (D-AR) commented; the $36.3 mil. adjustment includes a $23.1 mil. increase in Rx user fees, a $2.7 mil. transfer of funds for the FDA general counsel from Labor/HHS appropriations to the agriculture bill, the $6.5 mil. for mammography inspection fees and about $4 mil. in inflation adjustments, FDA says

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000905

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel